LG
Therapeutic Areas
SomaLogic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SomaSignal Tests for CVD | Cardiovascular Disease Risk (MI, Stroke, Heart Failure) | Development/Commercial (LDT) |
| SomaSignal Test for MASH/NASH | Metabolic Dysfunction-Associated Steatohepatitis | Development |
| SomaSignal Tests for Diabetes | Type 2 Diabetes Onset & Progression | Development |
| SomaSignal Tests for Neurology | Alzheimer's, Parkinson's, and other Neurological Diseases | Discovery/Development |
| SomaScan Assay Services | Biomarker Discovery & Translational Research | Commercial |